SCHEMBL2567154

SCHEMBL2567154

CN1CCc2ccc(NC(=O)C(C)(CCC(=O)N(C)C)NC(=O)Oc3ccc(Cl)s3)cc2CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.33
DRD2 P14416 2/20 0.33
HTR2C P28335 2/20 0.33
DRD3 P35462 2/20 0.33
HTR6 P50406 2/20 0.33
F10 P00742 2/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HTR2A P28223 1/20 0.33
CYP2C19 P33261 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2571214 0.87 KDM4E (0.40) ARDRD2HTR2CDRD3HTR6
SCHEMBL2568969 0.87 RAB9A (0.36) ARDRD2HTR2CDRD3HTR6
SCHEMBL2568110 0.87 HDAC1 (0.34) ARDRD2HTR2CDRD3HTR6
SCHEMBL3028065 0.87 F10 (0.44) ARF10RAB9ANPC1ALDH1A1
SCHEMBL2571305 0.85 KDM4E (0.36) ARDRD2HTR2CDRD3HTR6
SCHEMBL2571863 0.84 RAB9A (0.34) ARDRD2HTR2CDRD3HTR6
SCHEMBL2572738 0.83 ALOX5 (0.35) ARDRD2HTR2CDRD3HTR6
SCHEMBL2570993 0.82 NPC1 (0.33) ARDRD2HTR2CDRD3HTR6
SCHEMBL2568026 0.81 PSEN1 (0.33) ARDRD2HTR2CDRD3HTR6
SCHEMBL2569948 0.81 MEN1 (0.36) ARDRD2HTR2CDRD3HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP claimed
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP disclosed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP disclosed